Robert M. Cuddihy, MD

Robert M. Cuddihy, MD, is the Senior Vice President of Medical Affairs at Crinetics Pharmaceuticals, a position he has held since June 2024. He is a highly experienced clinician and executive in the pharmaceutical and biotech industries, with a strong background in endocrinology and medical affairs.

Professional Background

Dr. Cuddihy has an extensive career in medicine and healthcare management. Before joining Crinetics Pharmaceuticals, he served as the Section Chief of Endocrinology at Dartmouth Hitchcock Medical Center and Clinics. He is also a Senior Advisor to McKinsey & Company and has held various leadership roles in major pharmaceutical companies, including:

• Chief Executive Officer at Capsida Biotherapeutics, where he led significant growth and capital raising efforts.
• Vice President of US Medical Affairs at Amgen, overseeing multiple therapeutic areas.
• Global Medical Affairs roles at Janssen Pharmaceuticals and sanofi-aventis, focusing on cardiovascular and metabolic diseases.

In addition to his executive roles, Dr. Cuddihy has been involved in academia as an Assistant Professor of Medicine at the Mayo Clinic and has contributed to various medical organizations, including serving on the board of the American Diabetes Association.

Education and Certifications

Dr. Cuddihy is board-certified in Endocrinology, Diabetes, and Metabolism. His educational background includes significant training and experience in both clinical practice and medical research, enhancing his expertise in the pharmaceutical sector.

Contributions and Impact

Throughout his career, Dr. Cuddihy has been recognized for his leadership in medical affairs, contributing to the development and commercialization of numerous therapies. His work has emphasized improving patient care and advancing medical science, particularly in the field of endocrinology.123